not applicable.
Conditions
Interventions
Intervention 1: Intervention group: daily consumption of policosanol supplement 25 mg orally for three months, with lunch. Intervention 2: Control group: recipient of a 1 gram placebo capsule made in
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: People over 18 years old Male gender Willingness to cooperate Having a BMI between 18.5 and 29.9 Having at least three times a week for an hour of training each time Having at least one year of experience in Taekwondo
Exclusion criteria
Exclusion criteria: Unwillingness to participate in the study Suffering from metabolic diseases Presence of kidney diseases (acute or chronic kidney failure, etc.) and diagnosed bone diseases Smoking (cigarettes, hookah, drugs, etc.) Use of any supplements at the start of the study or 3 months before Following a special diet during the study Follow a specific practice while studying
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total antioxidant capacity. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Blood test.;Malondialdehyde. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Blood test.;Glutathione Peroxidase. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Blood test.;Superoxide dismutase. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Blood test.;Waist circumference. Timepoint: Before intervention and 3 months after intervention. Method of measurement: By measuring tape according to meter.;Hip circumference. Timepoint: Before intervention and 3 months after intervention. Method of measurement: By measuring tape according to meter.;Weight. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Digital scale.;Body mass index. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Body weight in kilograms divided by height squared in meters.;Total cholestrol. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Blood test.;Low-density lipoprotein. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Blood test.;High-density lipoprotein. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Blood test.;Triglyciride. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Blood test.;Fasting blood sugar. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Blood test.;Insulin. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Blood test.;Aerobic performance. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Bruce protocol.;Anaerobic performance. Timepoint: Before intervention and 3 months after intervention. Method of measurement: Wingat | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamidreza Razmi
Ahvaz University of Medical Sciences
Outcome results
None listed